No germline mutations in the dimerization domain of MXII in prostate cancer clusters
1997

No mutations found in MXI1 gene related to prostate cancer

Sample size: 38 publication Evidence: low

Author Information

Author(s): SM Edwards, DP Dearnaley, A Ardern-Jones, RA Hamoudi, DF Easton, D Ford, R Shearer, A Dowe, RA Eeles

Primary Institution: Institute of Cancer Research

Hypothesis

Is the MXI1 gene involved in inherited susceptibility to prostate cancer?

Conclusion

The study found no mutations in the MXI1 gene that would contribute to prostate cancer susceptibility.

Supporting Evidence

  • No mutations were found in the HLH and ZIP regions of the MXI1 gene.
  • The study analyzed 38 families with prostate cancer.
  • Familial clustering of prostate cancer suggests a genetic component.

Takeaway

The researchers looked for changes in a gene thought to be linked to prostate cancer in families with multiple cases, but they didn't find any.

Methodology

The HLH and ZIP regions of the MXI1 gene were sequenced in 38 families with prostate cancer.

Limitations

The study only examined specific regions of the MXI1 gene and may not account for other genetic factors.

Participant Demographics

Participants included families with multiple cases of prostate cancer, particularly those with cases diagnosed under age 67.

Statistical Information

Confidence Interval

Upper 95% confidence limit for MXII mutations is 7.6%.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication